Suchergebnisse - "Zhen, Yongqi"

PubPharm (17)

1

Discovery of a novel dual-target inhibitor of CDK12 and PARP1 that induces synthetic lethality for treatment of triple-negative breast cancer

enthalten in: European journal of medicinal chemistry | 2023

von Zhang, L. | Zhen, Y. | Feng, L. | +4

2

Unraveling the interplay between RAS/RAF/MEK/ERK signaling pathway and autophagy in cancer : From molecular mechanisms to targeted therapy

enthalten in: Biochemical pharmacology | 2023

von Huang, Y. | Zhen, Y. | Chen, Y. | +2

3

Flubendazole Enhances the Inhibitory Effect of Paclitaxel via HIF1α/PI3K/AKT Signaling Pathways in Breast Cancer

enthalten in: International journal of molecular sciences | 2023

von Zhou, Y. | Liao, M. | Li, Z. | +5

4

Deciphering the multifunctional role of dual leucine zipper kinase (DLK) and its therapeutic potential in disease

enthalten in: European journal of medicinal chemistry | 2023

von Bu, H. | Li, Z. | Lu, Y. | +3

5

Autophagy and beyond : Unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications

enthalten in: Acta pharmaceutica Sinica. B | 2022

von Zou, L. | Liao, M. | Zhen, Y. | +5

6

Flubendazole induces mitochondrial dysfunction and DRP1-mediated mitophagy by targeting EVA1A in breast cancer

enthalten in: Cell death & disease | 2022

von Zhen, Y. | Yuan, Z. | Zhang, J. | +6

7

Repurposing non-oncology small-molecule drugs to improve cancer therapy : Current situation and future directions

enthalten in: Acta pharmaceutica Sinica. B | 2022

von Fu, L. | Jin, W. | Zhang, J. | +7

8

Deconvoluting the Complexity of Reactive Oxygen Species (ROS) in Neurodegenerative Diseases

enthalten in: Frontiers in neuroanatomy | 2022

von Zhou, Y. | Zhen, Y. | Wang, G. | +1

9

Preparation of targeted Fam20C inhibitor and effect thereof in resisting triple negative breast cancer

enthalten in: Europäisches Patentamt | 2021

von ZHANG LAN | FU LEILEI | WANG GUAN | +2

10

Discovery of 5-bromo-4-phenoxy-N-phenylpyrimidin-2-amine derivatives as novel ULK1 inhibitors that block autophagy and induce apoptosis in non-small cell lung cancer

enthalten in: European journal of medicinal chemistry | 2020

von Sun, D. | Yang, Z. | Zhen, Y. | +6